 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
PharMerica Corporation (PMC) operates as an institutional pharmacy services company in the United States.
It offers services to healthcare facilities; management pharmacy services to hospitals; and specialty infusion services to patients outside hospitals. The company purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. It also provides consultant pharmacist services; medical records services; ancillary services, such as intravenous drug therapy products and services; and clinical services.
In addition, the company offers hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs. PharMerica Corporation operates approximately 91 institutional and 12 specialty infusion pharmacies in 45 states, as well as provides pharmacy management services to 89 hospitals.
Its customers primarily include institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings.
Shares have formed a bullish "flag" following the company's strong quarterly results. We are now hearing rumors of good news for this company.
One of the rumors states that this stock will be named by the leading stock advisory service as one of its "top picks." This service is widely followed by mutual funds and institutional money managers. These investors have portfolios that mimic recommendations of this service. Their naming of the stock should lead to additional demand for the shares.
52-Week Trading Range: $11.84 - 21.30
Entry Point: $20.51
Stop Loss: $19.54
Target Price: $22.65
PMC reached our target price. Position was closed at $22.65
